17β-Estradiol attenuates oxidative impairment of synaptic Na+/K+- ATPase activity, glucose transport, and glutamate transport induced by amyloid β-peptide and iron

Journal of Neuroscience Research

Volumn 50, Issue 4, 1997, Pages 522-530

  Keller, Jeffrey N ^a,b   Germeyer, Ariane ^b   Begley, James G ^b   Mattson, Mark P ^a,b,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Estrogen; Free radicals; Glucocorticoids; Hydroxynonenal; Lipid peroxidation; Mitochondrial electron transport; Neuronal death; Progesterone; Thiobarbituric acid

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMYLOID BETA PROTEIN; ESTRADIOL; GLUCOSE; GLUTAMIC ACID; IRON; MEMBRANE LIPID;

ALZHEIMER DISEASE; AMINO ACID TRANSPORT; ARTICLE; CEREBROVASCULAR ACCIDENT; ESTROGEN THERAPY; FEMALE; GLUCOSE TRANSPORT; HUMAN; LIPID PEROXIDATION; MEMBRANE TRANSPORT; NERVE DEGENERATION; PATHOGENESIS; PRIORITY JOURNAL; SYNAPSE; SYNAPTIC MEMBRANE; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MITOCHONDRION; OXIDATIVE STRESS; RAT; SPRAGUE DAWLEY RAT; SYNAPTOSOME; TRANSPORT AT THE CELLULAR LEVEL;

AMYLOID BETA-PROTEIN; ANIMALS; BIOLOGICAL TRANSPORT; ESTRADIOL; FEMALE; GLUCOSE; GLUTAMIC ACID; IRON; LIPID PEROXIDATION; MEMBRANE LIPIDS; MITOCHONDRIA; NA(+)-K(+)-EXCHANGING ATPASE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPSES; SYNAPTOSOMES;

EID: 0030608841     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19971115)50:4<522::AID-JNR3>3.0.CO;2-G     Document Type: Article

References (81)

1. Behl C, Davis JB, Lesley R, Schubert D (1994): Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77:817-827.
2. Behl C, Widmann M, Trapp T, Holsboer F (1995): 17-β Estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216:473-482.
3. Behl C, Lezoualch F, Trapp T, Widmann M, Skutella T, Holsboer F (1997): Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 138:101-106.
4. q/11. J Neurochem 69:570-580.
5. Blass JP (1993): Metabolic alterations common to neural and non-neural cells in Alzheimer's disease. Hippocampus 3:45-54.
6. Butterfield DA, Hensley K, Harris M, Mattson MP, Carney J (1994): β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: Implications to Alzheimer's disease. Biochem Biophys Res Commun 200:710-715.
7. Choi DW (1994): Calcium and excitotoxic neuronal injury. Ann NY Acad Sci 747:162-171.
8. DeKosky S, Scheff S (1990): Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann Neurol 27:457-464.
9. Dreher D, Junod AF (1996): Role of oxygen free radicals in cancer development. Eur J Cancer 32A:30-38.
10. Elliott E, Mattson MP, Vanderklish P, Lynch G, Chang I, Sapolsky RM (1993): Corticosterone exacerbates kainate-induced alterations in hippocampal tau immunoreactivity and spectrin proteolysis in vivo. J Neurochem 61:57-67.
11. Emerson CS, Headrick JP, Vink R (1993): Estrogen improves biochemical and neurologic outcome following traumatic brain injury in male rats, but not in females. Brain Res 608:95-100.
12. Ettinger B, Friedman GD, Bush T, Quesenberry CP (1996): Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecot 87:6-12.
13. Fiske CH, Subbarow Y (1925): The colorimetric determination of phosphorus. J Biol Chem 66:375-400.
14. Goodman Y, Mattson MP (1994): Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp Neurol 128:1-12.
15. Goodman Y, Steiner MR, Steiner SM, Mattson MP (1994): Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res 654:171-176.
16. Goodman Y, Bruce AJ, Cheng B, Mattson MP (1996): Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid β-peptide toxicity in hippocampal neurons. J Neurochem 66:1836-1844.
17. Green P, Gridley K, Simpkins J (1996): Estradiol protects against β-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci Lett 218:165-168.
18. Hall ED, Pazara KE, Linseman KL (1991): Sex differences in postischemic neuronal necrosis in gerbils. J Cereb Blood Flow Metab 11:292-298.
19. Hardy J (1997): Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20:154-159.
20. Harris ME, Camey JM, Cole PS, Hensley K, Howard BJ, Martin L, Bummer P, Wang Y, Pedigo NW, Butterfield DA (1995): β-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: Implications for Alzheimer's disease. NeuroReport 6:1875-1879.
21. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG (1994): Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and hondemented control subjects. Arch Neurol 51:896-900.
22. Horner HC, Packan DR, Sapolsky RM (1990): Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology 52:57-64.
23. Horvat A, Nikezic G, Martinovic JV (1995): Estradiol binding to synaptosomal plasma membranes of rat brain regions. Experientia 51:11-15.
24. Hoyer S (1991): Abnormalities of glucose metabolism in Alzheimer's disease. Ann NY Acad Sci 640:53-58.
25. Jagust WJ, Seab JP, Huesman RH, Valk PE, Mathis CA, Reed BR, Coxson PG, BudingerTF(1991): Diminished glucose transport in Alzheimer's disease: Dynamic PET studies. J Cereb Blood Flow Metab 11:323-330.
26. Joels M (1997): Steroid hormones and excitability in the mammalian brain. Front Neuroendocrinol 18:2-48.
27. Kalaria RN, Harik SI (1989): Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer's disease. J Neurochem 53:1083-1088.
28. Keaney SF Jr, Shwaery GT, Xu A, Nicolosi RJ, Loscalzo J, Foxall TL, Vita JA (1994): 17β-Estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation 89:2251-2259.
29. Keller JN, Pang Z, Geddes JW, Begley JG, Germeyer A, Waeg G, Mattson MP (1997): Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: Role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 69:273-284.
30. Kelly J, Furukawa K, Barger SW, Mark RJ, Rengen MR, Blanc EM, Roth G, Mattson MP (1996): Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc Natl Acad Sci USA 93:6753-6758.
31. Kennedy AM, Frackowiak RS, Newman SK, Bloomfield PM, Seaward J, Roques P, Lewington G, Cunningham VJ, Rossor MN (1995): Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease. Neurosci Lett 186:17-20.
32. Korachich GB, Mishra OP (1980): Lipid peroxidation in rat cortical slices as measured by the thiobarbituric acid test. J Neurochem 35:1449-1452.
33. Kruman I, Bruce-Keller AJ, Bredesen DE, Waeg G, Mattson MP (1997): Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 17:5097-5108.
34. Landfield PW, Thibault O, Mazzanti ML, Porter NM, Kerr DS (1992): Mechanisms of neuronal death in brain aging and Alzheimer's disease: Role of endocrine-mediated calcium dyshomeostasis. J Neurobiol 23:1247-1260.
35. LeBel CP, Bondy SC (1992): Oxidative damage and cerebral aging. Prog Neurobiol 38:601-609.
36. Lovell MA, Ehmann WO, Butler SM, Markesbery WR (1995): Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45:1594-1601.
37. 2+ homeostasis and cell death. J Neurosci 15:6239-6249.
38. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP (1997a): A role for 4-hydroxynonenal in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J Neurochem 68:255-264.
39. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP (1997b): Amyloid β-peptide impairs glucose uptake in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation. J Neurosci 17:1046-1054.
40. Massaeli H, Pierce GN (1995): Involvement of lipoproteins, free radicals, and calcium in cardiovascular disease processes. Cardiovasc Res 29:597-603.
41. Mattson MP, Mrotek J (1985): Exogenous steroids alter steroidogenesis in cultured Y-1 adrenal tumor cells by actions preceding cyclic AMP. Steroids 46:619-637.
42. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992): β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12:376-389.
43. 2+]i and neurotoxicity. and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem 65:1740-1751.
44. Mattson MP, Furukawa K, Bruce AJ, Mark RJ, Blanc EM (1996): Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia. In Wasco W, Tanzi RE(eds): "Molecular Mechanisms of Dementia." Totowa. NJ: Humana Press, pp 103-143.
45. Mattson MP, Fu W, Waeg G, Uchida K (1997): 4-Hydroxynonenal, a ptoduct of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau. NeuroReport 8:2275-2281.
46. Miller RJ, Murphy SN, Glaum SR (1989): Neuronal calcium channels and their regulation by excitatory amino acids. Ann NY Acad Sci 568:149-158.
47. Moccoci P, MacGarvey MS, Beal MF (1994): Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36:747-751.
48. Mosmann T (1983): Rapid colorimetric assay for cellular growth and survival. J Immunol Methods 65:55-63.
49. Novelli A, Reilly JA, Lyska PC, Henneberry RC (1988): Glutamate becomes neurotoxic via the N-methyl-D-aspanaie receptor when intracellular energy levels are reduced. Brain Res 451:205-212.
50. Olney JW, Fuller T, Gubareff TD (1979): Acute dendrotoxic changes in the hippocampus of kainate treated rats. Brain Res 176:91-100.
51. Oppong KN, Bartlett K, Record CO, Mardini H (1995): Synaptosomal glutamate transport in thioacetamide-induced hepatic encephalopathy in the rat. Hepatology 22:553-558.
52. Parthasarathy S, Morales AJ, Murphy AA (1994): Antioxidant: A new role for RU-486 and related compounds. J Clin Invest 94:1990-1995.
53. Paul SM, Purdy RH (1992): Neuroactive steroids. FASEB J 6:2311-2322.
54. Pettegrew JW, Panchalingam K, Klunk WE, McClure RJ, Muenz LR (1994): Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study. Neurobiol Aging 15:117-132.
55. 3H-glutamate transport in synaptosomes. Synapse 18:21-26.
56. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D (1996): Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 334:752-758.
57. Roof RL, Duvdevani R, Braswell L, Stein DG (1994): Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp Neurol 129:64-69.
58. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kunci PW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF (1996): Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675-686.
59. Ruiz-Larrea MB, Leal AM, Liza M, Lacort M, de Groot H (1994): Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids 59:383-388.
60. Sapolsky RM (1990): Glucocorticoids, hippocampal damage and the glutamatergic synapse. Prog Brain Res 86:13-23.
61. Schwartz J, Freeman R, Frishman W (1995): Clinical pharmacology of estrogens: Cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women. J Clin Pharmacol 35:314-329.
62. Selkoe DJ (1989): Biochemistry of altered brain proteins in Alzheimer's disease. Annu Rev Neurosci 12:463-490.
63. Shearman MS, Hawtin SR, Tailor VJ (1995): The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by β-amyloid peptides. J Neurochem 65:218-227.
64. Sherwin BB (1994): Estrogenic effects on memory in women. Ann NY Acad Sci 743:213-230.
65. Sims NR (1990): Altered glucose metabolism in Alzheimer's disease. Ann Neurol 27:691-693.
66. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR (1991): Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA 88:10540-10543.
67. Smith MA, Taneda S, Richey PL, Miyata S, Yan SD, Stern D, Sayre LM, Monnier VM, Perry G (1944): Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91:5710-5714.
68. Smith-Swintosky VL, Pettigrew LC, Sapolsky RM, Phares C, Craddock SD, Brooke SM, Mattson MP (1996): Metyrapone, an inhibitor of glucocorticoid production, reduces brain injury induced by focal and global ischemia and seizures. J Cereb Blood Flow Metab 16:585-598.
69. Subhiah MT, Kessel B, Agrawal M, Rajan R, Abplanalp W, Rymaszewski Z (1993): Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab 77:1095-1097.
70. Sze PY, Yu BH (1995): Glucocorticoid actions on synaptic plasma membranes: Modulation of dihydropyridine-sensitive calcium channels. J Steroid Biochem Mol Biol 55:185-192.
71. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R (1996): Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432.
72. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991): Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580.
73. Vitek MP, Bhatacharya K, Glendenmg JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A (1994): Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91:4766-4770.
74. Vogel CL (1996): Hormonal approaches to breast cancer treatment and prevention: An overview. Semin Oncol 23:2-9.
75. Volterra A, Trotti D, Tromba C, Floridi S, Racagni G (1994): Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J Neurosci 14:2924-2932.
76. Warren SG, Humphreys AG, Juraska JM, Greenough WT (1995): LTP varies across the estrous cycle: Enhanced synaptic plasticity in proestrus rats. Brain Res 703:26-30.
77. Whittaker VP, Michaelson JA, Kirkland RJA (1964): The separation of synaptic vesicles from nerve ending particles (synaptosomes). Biochem J 90:293-303.
78. Woolley CS, McEwen BS (1994): Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptordependent mechanism. J Neurosci 14:7680-7687.
79. Yan SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith MA, Perry G, Godman GC, Nawroth P, Zweier JL, Stern D (1995): Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nat Med 1:693-699.
80. Zhang Y, Tatsuno T, Carney J, Mattson MP (1993): Basic FGF, NGF, and IGFs protect hippocampal neurons against iron-induced degeneration. J Cereb Blood Flow Metab 13:378-388.
81. Zbou Y, Gopalakrishnan V, Richardson JS (1996): Actions of neurotoxic β-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists. J Neurochem 67:1419-1425.